UroGen Pharma (NASDAQ:URGN) Shares Gap Down on Disappointing Earnings
UroGen Pharma Ltd. (NASDAQ:URGN – Get Free Report) shares gapped down before the market opened on Monday following a weaker than expected earnings announcement. The stock had previously closed at $10.38, but opened at $9.90. UroGen Pharma shares last traded at $11.19, with a volume of 402,553 shares trading hands. The company reported ($0.92) earnings […]
